Relationships of soluble E-selectin and high-sensitivity C-reactive protein with carotid atherosclerosis in Japanese

Susumu Sakurai1, Akihiko Kitamura, Renzhe Cui

  • 1Department of Public Health, Doctoral Program in Social Medicine, Graduate School of Medicine, Ehime University, Ehime, Japan.

Insights

Soluble E-selectin (sE-selectin) and high-sensitivity C-reactive protein (hs-CRP) are associated with carotid atherosclerosis. Higher levels of these biomarkers correlate with increased carotid intima-media thickness and plaque prevalence in Japanese men.

Area of Science:

  • Cardiovascular Medicine
  • Biomarkers
  • Atherosclerosis Research

Background:

  • E-selectin and C-reactive protein are implicated in carotid atherosclerosis.
  • Previous findings on their association with carotid atherosclerosis have been inconsistent.

Purpose of the Study:

  • To investigate the association of soluble E-selectin (sE-selectin) and high-sensitivity C-reactive protein (hs-CRP) with carotid intima-media thickness (IMT).
  • To evaluate the relationship between these biomarkers and the prevalence of heterogeneous plaque in Japanese men.

Main Methods:

  • Cross-sectional study involving 505 Japanese men aged 60-74 years.
  • Measurement of serum sE-selectin and hs-CRP levels.
  • Assessment of maximum carotid intima-media thickness (IMT) in common (CCA) and internal carotid arteries (ICA).
  • Statistical analysis adjusted for age, cardiovascular risk factors, and other biomarkers.

Main Results:

  • sE-selectin levels were positively associated with maximum CCA and ICA IMT.
  • hs-CRP levels showed a trend towards positive association with maximum CCA IMT.
  • Higher tertiles of both sE-selectin and hs-CRP were associated with a higher prevalence of heterogeneous plaque.

Conclusions:

  • Serum levels of sE-selectin and hs-CRP may serve as potential biomarkers for atherosclerosis.
  • These findings suggest their utility in assessing atherosclerosis risk in the general population.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Selectins01:25

Selectins

Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain, which...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...